How to design effective vaccines: Lessons from an old success story

Expert Review of Vaccines

Volumn 8, Issue 5, 2009, Pages 543-546

  Ahmed, Nabil ^a,b   Gottschalk, Stephen ^a,b  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1BETA; STAT1 PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; YELLOW FEVER VACCINE;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG DESIGN; DRUG EFFECT; DRUG POTENCY; FLOW CYTOMETRY; GENE INDUCTION; GENOMICS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VITRO STUDY; INNATE IMMUNITY; NATURAL KILLER CELL; NOTE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; UPREGULATION; VACCINATION; YELLOW FEVER; GENETICS; IMMUNOLOGY; REVIEW;

HUMANS; IMMUNITY, INNATE; TH1 CELLS; TH2 CELLS; YELLOW FEVER; YELLOW FEVER VACCINE;

EID: 65649150652     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.09.26     Document Type: Note

References (23)

1. Riedel S. Edward Jenner and the history of smallpox and vaccination. Proc. Bayl. Univ. Med. Cent. 18, 21-25 (2005).
2. Amanna IJ, Slifka MK, Crotty S. Immunity and immunological memory following smallpox vaccination. Immunol. Rev. 211, 320-337 (2006). (Pubitemid 43882983)
3. Lambert PH, Liu M, Siegrist CA. Can successful vaccines teach us how to induce efficient protective immune responses? Nat. Med. 11(4 Suppl.), S54-S62 (2005). (Pubitemid 40562304)
4. Li PG, Kern F, Gratama J, Roederer M, Manca F. Measurement of antigen specific immune responses: 2006 update. Cytometry B Clin. Cytom. 72, 77-85 (2007).
5. Plotkin SA. New vaccination strategies. Bull. Acad. Natl Med. 192, 511-518 (2008).
6. Plotkin SA. Vaccines: correlates of vaccine-induced immunity. Clin. Infect. Dis. 47, 401-409 (2008).
7. Qin L, Gilbert PB, Corey L, Mcelrath MJ, Self SG. A framework for assessing immunological correlates of protection in vaccine trials. J. Infect. Dis. 196, 1304-1312 (2007).
8. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7, 179-190 (2007). (Pubitemid 46310482)
9. Siber GR, Chang I, Baker S et al. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine 25, 3816-3826 (2007). (Pubitemid 46589754)
10. + T-cell responses are required for clearance of West Nile virus from the central nervous system. J. Virol. 80, 12060-12069 (2006).
11. Denoël PA, Goldblatt D, de Vleeschauwer I, Jacquet JM, Pichichero ME, Poolman JT. Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines. Clin. Vaccine Immunol. 14, 1362-1369 (2007). (Pubitemid 350012980)
12. Huber VC, Mckeon RM, Brackin MN et al. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin. Vaccine Immunol. 13, 981-990 (2006). (Pubitemid 44518965)
13. van der Zeijst BA, Dijkman MI, Luytjes W, van Alphen AJ, van den Dobbelsteen GP. On the design of national vaccination programmes. Vaccine 25, 3143-3145 (2007). (Pubitemid 46482756)
14. Gaucher D, Therrien R, Kettaf N et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119-3131 (2008).
15. Reinhardt B, Jaspert R, Niedrig M, Kostner C, L'Age-Stehr J. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J. Med. Virol. 56, 159-167 (1998). (Pubitemid 28419278)
16. Michalik DE, Steinberg SP, Larussa PS et al. Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J. Infect. Dis. 197, 944-949 (2008).
17. Panchanathan V, Chaudhri G, Karupiah G. Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function. J. Virol. 80, 6333-6338 (2006). (Pubitemid 43927436)
18. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009).
19. Rimmelzwaan GF, Mcelhaney JE. Correlates of protection: novel generations of influenza vaccines. Vaccine 26(Suppl. 4), D41-D44 (2008).
20. Panchanathan V, Chaudhri G, Karupiah G. Correlates of protective immunity in poxvirus infection: where does antibody stand? Immunol. Cell Biol. 86, 80-86 (2008).
21. Desselberger U, Manktelow E, Li W, Cheung W, Iturriza-Gomara M, Gray J. Rotaviruses and rotavirus vaccines. Br. Med. Bull. DOI: 10.1093/bmb/ldp009 (2009) (Epub ahead of print).
22. Bambini S, Rappuoli R. The use of genomics in microbial vaccine development. Drug Discov. Today 14, 252-260 (2009).
23. Churchill W. Speech at Lord Mayor's Luncheon, Mansion House following the victory at El Alameinin, North Africa. London, UK, 10 November 1942.